<p>n: number of resistance tests (first test/patient per year) presenting with mutations associated to resistance; N: Total number of patients with resistance test in that period; CI: confidence interval; Significant effects (P≤0.05) are bolded. NS: not significant.</p><p>Treatment-experienced patients with drug resistance: frequency (%) of drug resistance over time, by drug class and their dual or triple combinations.</p
<p>Frequency of antiretroviral resistance mutations at selected codons associated with decreased sus...
<p>Likely effective, drugs to which isolate susceptible in laboratory testing. <i>n</i>, number of p...
The proportion of drug-resistant mutations selected by antiretroviral drug classes among adolescents...
<p>Frequency of baseline drug resistance mutations among treatment-naive patients.</p
The proportion of drug-resistance mutations selected by ARV classes showing dual and triple class re...
<p><b>A</b> Proportion of resistance mutations in first Prot/RT sequence from treatment naïve patien...
<p>DRM: Drug resistance mutations; NRTI: Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; NNR...
The proportion of drug-resistant mutations selected by non-nucleoside reverse transcriptase inhibito...
<p>Statistically significant p-values (<0.05) are in boldface</p>a<p>Number of patients with resista...
The proportion of drug-resistant mutations selected by the nucleoside reverse transcriptase inhibito...
(the number/percentage of drug-resistant strains and 95% confidence interval (CI), %).</p
<p>Prevalence of susceptible (S, solid bars), intermediate (I, striped bars) or high-level resistanc...
<p>Percentage of sequences having resistance mutations to NRTI (red), NNRTI (yellow), PI (green), an...
The proportion of drug-resistant mutations selected by protease inhibitors among adolescents and you...
<p>Legend: DST = Drug susceptibility test; Drug resistant = any drug resistance, including MDR; MDR ...
<p>Frequency of antiretroviral resistance mutations at selected codons associated with decreased sus...
<p>Likely effective, drugs to which isolate susceptible in laboratory testing. <i>n</i>, number of p...
The proportion of drug-resistant mutations selected by antiretroviral drug classes among adolescents...
<p>Frequency of baseline drug resistance mutations among treatment-naive patients.</p
The proportion of drug-resistance mutations selected by ARV classes showing dual and triple class re...
<p><b>A</b> Proportion of resistance mutations in first Prot/RT sequence from treatment naïve patien...
<p>DRM: Drug resistance mutations; NRTI: Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; NNR...
The proportion of drug-resistant mutations selected by non-nucleoside reverse transcriptase inhibito...
<p>Statistically significant p-values (<0.05) are in boldface</p>a<p>Number of patients with resista...
The proportion of drug-resistant mutations selected by the nucleoside reverse transcriptase inhibito...
(the number/percentage of drug-resistant strains and 95% confidence interval (CI), %).</p
<p>Prevalence of susceptible (S, solid bars), intermediate (I, striped bars) or high-level resistanc...
<p>Percentage of sequences having resistance mutations to NRTI (red), NNRTI (yellow), PI (green), an...
The proportion of drug-resistant mutations selected by protease inhibitors among adolescents and you...
<p>Legend: DST = Drug susceptibility test; Drug resistant = any drug resistance, including MDR; MDR ...
<p>Frequency of antiretroviral resistance mutations at selected codons associated with decreased sus...
<p>Likely effective, drugs to which isolate susceptible in laboratory testing. <i>n</i>, number of p...
The proportion of drug-resistant mutations selected by antiretroviral drug classes among adolescents...